Difference between revisions of "Team:Michigan/Modeling"

Line 108: Line 108:
 
         <h1 style="text-align:center; font-size: 50px;"> <font face= "Poiret One">Overview</h2>
 
         <h1 style="text-align:center; font-size: 50px;"> <font face= "Poiret One">Overview</h2>
 
<br>
 
<br>
<p style="text-align:center; font-size:20px;"><font face="verdana">The ligation of aptamer 1 to the biomarker is independent to the ligation of aptamer 2 to the biomarker; in other words, the binding of an aptamer to the protein would not make the binding of the second aptamer less or more likely. Only one aptamer molecule may bind at a time to a target molecule. We are assume that gibbs free energy of the reaction at equilibrium of the reaction will never exactly be zero. The dozens of aptamer-protein dynamics will although approach zero, will not be exactly zero.</p>
+
<p style="text-align:center; font-size:20px;"><font face="verdana">The mathematical model of the proximity dependent ligation involves the following molecules/initial reactants:</p>
 +
<img src="https://static.igem.org/mediawiki/2016/3/33/Modeling_Overview_Chart_2.JPG"><br>
 
     </div>
 
     </div>
  

Revision as of 21:37, 18 October 2016

Mathematical Model

Introduction


Mathematical models greatly aid in the prediction of the outcome of a biological design. Our mathematical model will be employed to test the efficacy of an aptamer based proximity-dependent ligation assay (PLA) in the detection of biomarkers. The proximity dependent ligation assay is an extension to the traditional immunoassay and can be used for protein detection with high specificity and sensitivity. The selectivity of the proximity dependent ligation assay is dramatically enhanced through the double recognition by two oligonucleotide-conjugated aptamers. We sought to optimize the aptamer-protein equilibria to promote the efficient and precise binding of the aptamer with the target molecule.


Methodology


Using Wolfram Mathematica 10.4, a symbolic mathematical computation program, we will evaluate the minimum Gibbs Free Energy (G) of the aptamer-protein complex for different concentrations of the initial reactants: aptamer 1 ([A1]), aptamer 2 ([A2]), the connector oligonucleotide ([C]), and the target protein ([P]). By finding the minimum Gibbs Free Energy of the system, we will be able to find the concentrations of the final aptamer-protein complexes at chemical equilibrium. The possible aptamer protein complexes at chemical equilibrium include: unbound aptamer 1 [A1], unbound aptamer 2 [A2], unbound connector [C], unbound protein target [P], aptamer 1 and protein complex [A1P], aptamer 2 and protein complex [A2P], aptamer 1, aptamer 2, and protein complex [A1A2P], aptamer 1 and connector complex [A1C], aptamer 2 and connector complex [A2C],  aptamer 1, aptamer 2, and connector complex [A1A2C], aptamer 1, protein, and connector complex [A1PC], aptamer 2, protein, and connector complex [A2PC], and the aptamer 1, aptamer 2, protein and connector complex [A1A2PC]. By calculating the concentrations of the above aptamer-proteins complexes at chemical equilibrium at different initial concentrations of the reactants, we can optimize the aptamer-protein equilibria to promote the sensitivity of the aptamer in the presence of the target protein, while lowering the formation of an aptamer-protein complex when there is a lack of the target protein (non-specific reaction formation).

Assumptions


The ligation of aptamer 1 to the biomarker is independent to the ligation of aptamer 2 to the biomarker; in other words, the binding of an aptamer to the protein would not make the binding of the second aptamer less or more likely. Only one aptamer molecule may bind at a time to a target molecule. We are assume that gibbs free energy of the reaction at equilibrium of the reaction will never exactly be zero. The dozens of aptamer-protein dynamics will although approach zero, will not be exactly zero.

Overview


The mathematical model of the proximity dependent ligation involves the following molecules/initial reactants:


Conclusion


In order to confirm that our mathematical model was, indeed, functional, we confirmed the patterns that were to be predicted in the model. For example, a higher Kd value would lead to less aptamer-protein complex formation. As expected, this pattern was seen in our model, as a 2-fold decrease in the Kd value, generally led to a greater than 10-fold decrease in the protein-aptamer complex that was expected to form.

Our mathematical model was also able to show that lower concentrations of the protein with constant concentrations of aptamer 1, aptamer 2, and the connector would lead to lower overall complex formations. In other words, when the protein is missing in the system, it is very unlikely for unspecific reactions to take place, and thereby give a false positive signal. As the protein concentration was gradually increased, the number of aptamer-protein complexes increased at an exponential rate, indicating the sensitivity of the aptamer-protein complex. In other words, only a small amount of the target protein is needed for the complex to form.

To further characterize our system, we would need to modify the concentrations of aptamer 1, aptamer 2, and the connector at a constant protein concentration to find the concentrations of reactants that would optimize the highly sensitive formation of the aptamer-protein complex in the presence of a protein. Unfortunately, with our oversimplified model, no clear pattern was seen when the concentrations of aptamer 1, aptamer 2, and the connector was modified. We are only able to provide conclusions on the general patterns that were seen when the protein concentration was modified. This pattern was also limited to a specific range of protein concentrations (insensible reactant concentrations and gibbs free energy values were seen at several protein concentrations that were tested). A more realistic mathematical model would be needed to quantitatively, rather than qualitatively, discern the complex behavior of the proximity dependent ligation assay.